SS18L1 Gene Amyotrophic Lateral Sclerosis CREST Related NGS Genetic DNA Test
Comprehensive Genetic Testing for Neurological Disorders
The SS18L1 Gene Amyotrophic Lateral Sclerosis CREST Related NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced testing method utilizes Next-Generation Sequencing (NGS) technology to identify specific mutations in the SS18L1 gene that are associated with both Amyotrophic Lateral Sclerosis (ALS) and CREST syndrome. Understanding your genetic predisposition to these conditions can provide crucial insights for early intervention and personalized treatment approaches.
What This Test Measures and Detects
This comprehensive genetic analysis specifically targets the SS18L1 gene, which plays a critical role in neurological function and autoimmune regulation. The test identifies:
- Point mutations and single nucleotide variations in the SS18L1 gene
- Insertions and deletions that may affect gene function
- Genetic markers associated with increased ALS risk
- Variants linked to CREST syndrome development
- Inheritance patterns for family risk assessment
Who Should Consider This Test
This genetic test is particularly recommended for individuals experiencing:
- Progressive muscle weakness or atrophy
- Family history of ALS or motor neuron disease
- Unexplained neurological symptoms
- Autoimmune conditions with neurological components
- Early signs of CREST syndrome (Calcinosis, Raynaud’s phenomenon, Esophageal dysmotility, Sclerodactyly, Telangiectasia)
- Difficulty with speech, swallowing, or breathing
- Muscle twitching or cramping
Benefits of Genetic Testing
Undergoing the SS18L1 genetic test provides numerous advantages:
- Early Detection: Identify genetic risks before symptoms become severe
- Personalized Treatment: Develop targeted treatment strategies based on genetic profile
- Family Planning: Understand inheritance risks for future generations
- Accurate Diagnosis: Differentiate between similar neurological conditions
- Peace of Mind: Reduce uncertainty about genetic predisposition
- Research Contribution: Help advance understanding of neurological disorders
Understanding Your Test Results
Your genetic test results will be thoroughly explained by our genetic counseling team. Possible outcomes include:
- Positive Result: Indicates the presence of SS18L1 gene mutations associated with increased ALS/CREST risk
- Negative Result: No detected mutations in the analyzed gene regions
- Variant of Uncertain Significance: Genetic changes with unknown clinical impact requiring further evaluation
All results include comprehensive genetic counseling to help you understand the implications and next steps.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about your genetic risk for ALS and CREST syndrome affect your quality of life. Our comprehensive SS18L1 genetic testing provides the clarity you need to make informed healthcare decisions. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood drops, getting tested has never been more convenient.
Ready to take the next step? Call our genetic specialists today at +1(267) 388-9828 to schedule your appointment or book your test online. Our team is available to answer your questions and guide you through the testing process.
